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Abstract
Background: Mental health problems have an adverse effect on the course of cardiac disease. The integration of their
diagnosis and treatment into cardiology care is generally poor. It is particularly challenging in cultural environments
where mental health problems are stigmatized. The objective of the current study was to investigate the proportion of
cardiac patients with depression and anxiety as well as factors associated with the presence of these symptoms in a
Palestinian population.
Methods: This cross-sectional hospital-based study was conducted on patients consecutively admitted with a new or
existing cardiac diagnosis to one of the four main hospitals in Nablus, Palestine over an eight-month period. Data was
obtained from hospital medical charts and an in-person interview, using a structured questionnaire with a sequence of
validated instruments. All subjects were screened for depression and anxiety using the Cardiac Depression Scale (CDS)
and the Depression Anxiety Stress Scale (DASS-42). Multivariate ordered logistic regression analyses were performed to
identify factors among four categories (socio-demographic, clinical, psychosocial, lifestyle) independently associated
with depression and anxiety.
Results: In total, 1053 patients with a confirmed cardiac diagnosis were included in the study with a participation rate of
96%. Based on the CDS and DASS-42, 54% met the criteria for severe depression (CDS > 100) and 19.2% for severe-to-
very severe anxiety (DASS-anxiety > 15), respectively. Symptoms of depression and anxiety were more prevalent among
females and less educated patients. Factors independently associated with both depressive and anxiety symptoms were
post-traumatic stress disorder symptoms, low level of self-esteem, high somatic symptoms, low physical and mental
health component scores, active smoking, physical inactivity, and longer disease duration. Patients with depressive and
anxiety symptoms also reported poor social support and lower resilience.
Conclusion: There was a high level of depression and anxiety in this sample of cardiac patients. The results point to
characteristics of patients in particular need for mental health screening and suggest possible targets for intervention
such as strengthening of social support and of physical activity. The integration of mental health services into cardiac
rehabilitation in Palestine and comparable cultural settings is warranted from the time of first diagnosis and onward.
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Background
Cardiovascular diseases (CVDs) and depression are
among the leading causes of the global disease burden
[1]. CVDs are the most common cause of death ac-
counting for 17.9 million deaths globally, in 2015 [2].
Depression affects over 300 million people around the
world [3], and is expected to become the main cause of
disability globally, in 2030 [4]. Similarly, in 2010, anx-
iety affected approximately 272 million people, world-
wide [5].
There is a high prevalence of mental disorders, particu-
larly depression and anxiety, in CVD patients [6]. The bi-
directional link between CVDs and these mental disorders
has been extensively documented in literature [7–9]. Ap-
proximately, 15–30% of patients with CVD suffer from
depressive disorders [10–14]. These rates of depression
are two to three times higher than in the general popula-
tion [15]. Moreover, depression and anxiety have been
found to worsen prognosis and quality of life in patients
with coronary artery disease (CAD), myocardial infarction
(MI), heart failure (HF), unstable angina, and coronary
artery bypass grafting (CABG) [16–22]. CABG is defined
as a surgical procedure that is performed to treat people
who have severe coronary heart disease, which improves
blood flow to the heart [23]. They were also found to be
the biggest driver of health care costs in coronary heart
disease (CHD) patients [24].
Mental health problems have a direct physiological
effect on the course of cardiac disease and their adverse
effect may be mediated by non-compliance to lifestyle
interventions, treatment and medication [25, 26]. Fur-
thermore, these mental disorders add to the burden of
managing CVD, from a perspective of treatment com-
plexity and emotional distress. This problem is further
aggravated by the high rate of additional co-morbidities
such as diabetes, hypertension and obesity [27].
The American Heart Association (AHA) has recom-
mended routine depression screening in cardiac patients
[26]. However, health systems have not yet adequately
responded and less than 15% of cardiac patients are being
diagnosed and treated for depression [28]. Integrating
mental health into cardiac treatment is of particular rele-
vance in low-middle-income countries (LMICs), where the
burden of depression and anxiety is often high and aggra-
vated by adverse life and political conditions. Similarly,
mental health problems are stigmatized in many of these
non-western cultures [29]. Little is known on the preva-
lence of depression and anxiety among cardiac patients in
LMICs [30]. This also applies to Palestine, where mental
disorders commonly are not recognized, diagnosed or
treated, despite the increase in their prevalence [31]. Unad-
dressed mental care needs may be an important barrier to
the successful management of cardiac patients in Palestine,
where CVD remains the leading cause of death [32].
Mental health problems have not been studied in
cardiac patients in the Palestinian population. Therefore,
the aim of the current study was to determine the pro-
portion of patients with depression and anxiety symp-
toms admitted with a cardiac diagnosis, to one of the
four main hospitals in Nablus, Palestine. To guide physi-
cians in effective mental health screening in the future,
we also identified socio-demographic, clinical, psycho-
social, and lifestyle factors associated with a high risk of
depression and anxiety symptoms.
Methods
Study design and population
This cross-sectional hospital-based study was conducted
on patients consecutively admitted to the cardiology and
cardiac surgery departments of An-Najah National Uni-
versity Hospital, Arab-Specialized Hospital, Watani Hos-
pital and Nablus Specialized Hospital in the Northern
West Bank city of Nablus, Palestine. Patients were eli-
gible for the study if they were between 30 and 80 years
of age and had an existing or newly confirmed cardiac
diagnosis warranting hospitalization during the period
between March and November 2017. In the present
study, cardiac diagnoses considered included CAD, ST
elevation or non-ST elevation MI, angina, HF, cardiac
arrhythmia, valve disease or any other cardiac disease.
Diagnoses were confirmed using hospital medical charts.
Patients were excluded if they had a normal cardiac
catheterization (CATH), an acute or past stroke, end-stage
kidney disease (including dialysis patients), peripheral vas-
cular disease, major co-morbidities affecting mental health
(alcohol abuse, drug abuse), neurological disorders (de-
mentia, Alzheimer’s disease, epilepsy, Parkinson’s disease),
cognitive impairment, a severe clinically diagnosed psychi-
atric condition or any other condition affecting the quality
of their responses.
Eligible patients were recruited for in-person interviews
by trained medical research assistants. Patients were iden-
tified using hospital registries and medical records. Inter-
views were conducted while patients were awaiting
treatment (after CATH) or after their treatment, within 1
week of their admission to the hospital. Eligible patients
were informed about the study objectives and benefits and
written informed consent was obtained from those who
agreed to participate. The study was approved by the Eth-
ics Committee of Nordwest-und Zentral Schweiz (EKNZ)
in Basel, Switzerland, and by the Institutional Review
Board (IRB) committee at An-Najah National University
in Nablus, Palestine.
Study assessments and measures
Data was collected using a structured questionnaire con-
sisting of two parts (Tables 1 and 2; see Additional file 1
for more detailed description). The first part included
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detailed socio-demographic and clinical information ob-
tained from patients’ administrative and medical charts.
The second part was administered during a private
interview and consisted of a sequence of screening in-
struments. These validated tools have demonstrated to
be suitable for clinical populations to assess for depres-
sion and anxiety symptoms, QoL, post-traumatic stress
disorder (PTSD), social support, resilience, self-esteem,
somatic symptoms and lifestyle behaviors. The question-
naire, including the instruments, was translated from
English to Arabic and back-translated from Arabic to
English by two bilingual experts.
Statistical analyses
The primary endpoints in the present study were depres-
sion and anxiety. Descriptive statistics for stress as an
endpoint are presented in an Additional file 2: Table S2,
with no further description. The four predictor blocks
investigated for association with depression and anxiety
were socio-demographic, clinical, psychosocial and life-
style factors (Table 1). Endpoints and predictors were
described as means and standard deviations (SD) for
quantitative variables and as absolute values and percent-
ages for categorical variables. Differences in predictor vari-
ables according to presence or absence of depression and
anxiety symptoms were described using chi-squared test
and the Wilcoxon rank sum test, as appropriate. Fisher’s
exact test was used for results presenting a frequency
below five. Multivariate ordered logistic regression ana-
lyses were performed to examine the independent associ-
ation between predictor variables and depression or
anxiety symptoms. All variables were entered in each of
the models at once. Results are presented in separate
models for depression and anxiety and are expressed as
odds ratio (OR) and 95% confidence intervals (95% CI).
The cut-offs for the respective outcome variables were
normal, mild/moderate, and severe/very severe according
to standardized cut-offs. Correlations between the out-
come variables and other instruments used in the study
were assessed using Spearman’s rank correlation coeffi-
cient. Cronbach alpha was used to assess the internal
consistency of the different scales. Statistical significance
was defined as a two-sided p-value <0.05. All data was an-
alyzed using the STATA Data Analysis and Statistical Soft-
ware, version 14.
Results
In total, 1092 patients were eligible and approached for an
interview. Among the 1053 (96%) patients which agreed
to participate in the study, 1022 patients with complete
outcome and predictor information were used in the
analysis.
Characteristics of study population
Characteristics of the participants are presented in
Table 3.
Socio-demographic factors
Among the 1022 patients, 73.4% were males. The mean
age of patients was 58.9 ± 10.1 years (range 30–80 years).
The majority of participants were married (90.6%), 37%
were unemployed, and 58.7% did not have a high school
diploma. Most of the study population lived in cities
(46.4%) or villages (46.3%), while 7.3% resided in refu-
gee camps.
Clinical factors
The primary diagnoses among the sample were MI
(39.7%), CAD (32.7%), angina (15.9%) and other diagnoses
(11.7%), including mitral or aortic valve stenosis, valve
regurgitation, heart block and others. Among the category
of other diagnoses, 29 (2.8%) patients had heart failure.
Over 60% of participants had a previous cardiac diagnosis
and had been diagnosed with a cardiac disease for 1 year
or less. About half of participants underwent a CATH
with a stent (52.2%), while others underwent a CATH with
a CABG (23.5%), or some kind of other procedure
(24.3%), which was not yet performed at the time of the
interview. Forty one percent of participants reported
having two or more co-morbidities (mainly diabetes and
hypertension) and 72.2% were on three or more medica-
tions. In addition, more than half of the participants’
reported a family history of CVD. Approximately 37% of
participating patients exhibited high somatic symptoms
Table 1 Predictor blocks used in bivariate and ordered logistic regression analyses
Block Variable
1 Socio-demographic factors Age, gender, marital status, residence, education level, occupation
2 Clinical factors Current diagnosis, previous cardiac diagnoses, years with cardiac disease, cardiac treatment (at admission),
co-morbidities, medications, somatic symptoms (PHQ-15), family history of CVD, QoL (SF-12-PCS)
3 Psychosocial factors PTSD (PTSD-PCL-S), social support (ESSI), resilience (RS-14), self-esteem, QoL (SF-12-MCS)
4 Lifestyle factors Smoking status, currently on diet, fat consumption, vegetable and fruit consumption, alcohol use, physical activity, BMI
Note. CVD Cardiovascular disease, QoL Quality of life, PHQ-15 Patient health questionnaire-15, PCS Physical component summary, PTSD Post-traumatic stress
disorder, PTSD-PCL-S Post-traumatic stress disorder checklist, ESSI ENRICHD Social support instrument, RS-14 Resilience scale-14, MCS Mental component summary,
BMI Body mass index
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on the PHQ-15. The mean score of the participants on
the SF-12- PCS score was 37.6 ± 12.4.
Psychosocial factors
Forty Percent of patients reported having PTSD symp-
toms on the PTSD-PCL-S. Social support was generally
high (64%) among participants, according to the ESSI.
Almost half of the participants presented with moderate
to moderately-high resilience. The mean score for
self-esteem was 5.8 ± 1.4, while the mean score for the
SF-12-MCS was 39.7 ± 13.2.
Lifestyle factors
Almost half of the participants were current smokers
while 35.6% had never smoked before. The vast majority
of participants (83.4%) reported not being on a diet, 47%
low fat consumption, and 55.5% high vegetable and fruit
consumption. The reported alcohol consumption was
very low with 95% of participants not consuming any
alcohol. Almost half of the patients reported no-to-min-
imal daily physical activity. Eighty percent of patients
were either overweight or obese.
Proportion of patients with depressive and anxiety
symptoms at different severity levels
Table 4 shows the proportion of patients with depression
(CDS), depression (DASS-depression), anxiety (DAS-
S-anxiety) and stress (DASS-stress) symptoms at differ-
ent severity levels. Cutoffs for the levels of CDS and
DASS subscales are also presented in Table 4. Based on
our findings, the mean ± SD depression score on the
CDS was 101.3 ± 15.6 and the overall proportion of
patients with depression was 78.7%. According to the
recommended cutoffs for the CDS, 21.3, 25.2 and 53.5%
of the sample had no, mild-to-moderate and severe-to-v-
ery severe depression symptoms, respectively. The
means ± SDs on the DASS-42 were 9.4 ± 8.6, 9.4 ± 6.8
and 15.2 ± 9 for depression, anxiety, and stress, respect-
ively. It was found that the overall proportion was 52.9,
53.1 and 37.4% for the presence of depressive, anxiety
and stress symptoms according to the DASS-42. Based
on recommended cutoffs, 47.1, 33.4 and 19.5% of pa-
tients reported normal, mild-to-moderate and severe-
to-very severe depressive symptoms (DASS-depression).
In addition, 46.9% patients did not report any anxiety,
Table 2 Study Instruments (see Additional file 1 for further descriptions)
Instrument Description
Outcomes - assessment of
depression, anxiety and stress
Cardiac Depression (CDS) The primary outcome of the study was measured using the Cardiac Depression Scale (CDS) by Hare et al., a
disease-specific, 26-item questionnaire used to measure depression in patients with CVDs. CDS scores range from
26 to 182, and items are scored on a seven-point Likert scale from 1 (strongly disagree) to 7 (strongly agree) [60].
The CDS can be used as a continuous measure, where higher scores indicate higher depressive symptoms or as
an ordinal indicator of possible depression using cut-off points previously used in literature. In this study, the
presence of mild-to-moderate depression was defined as a CDS score of 90–100 and the presence of severe de-
pression as a score >100. Scores below 90 indicated no-to-minimal depression [63].
Depression, anxiety, stress
(DASS-42)
Depression (DASS-depression), anxiety (DASS-anxiety) and stress (DASS-stress) were measured using the
Depression Anxiety Stress Scale-42 (DASS-42) by Lovibond & Lovibond, a 42-item questionnaire consisting of
three subscales, each containing 14 items scored on a four-point Likert scale ranging from 0 (did not apply to
me at all) to 3 (applied to me very much), measuring the extent to which each item was experienced over the
past week. The scores are classified as: depression 0–9 (normal), 10–20 (mild-moderate), > 21 (severe-very severe);
anxiety 0–7 (normal), 8–14 (mild-moderate), > 15 (severe-very severe); stress 0–14 (normal); 15–25 (mild-moder-
ate), > 26 (severe-very severe) [64].
Predictors – correlates of
depression and anxiety
Somatic Symptoms (PHQ-15) The Patient Health Questionnaire (PHQ-15) is a 15-item somatic symptom scale derived from the full Patient-
Health-Questionnaire to measure the severity of somatization in patients [65].
Quality of life (SF-12-PCS; SF-12-
MCS)
Quality of life was assessed using the 12-item Short-Form Health Survey (SF-12), which is a generic measure of
overall health status. The SF-12 is comprised of two components, the Mental Component Summary (MCS) score
and the Physical Component Summary (PCS) score [66].
Post-traumatic stress disorder
(PTSD-PCL-S)
The Post-Traumatic Stress Disorder Checklist (PTSD-PCL-S) is a 17-item scale used to assess PTSD symptoms based
on the Diagnostic and Statistical Manual of Mental Disorders (DSM IV) criteria. The PTSD-PCL-S is used to link
symptom endorsements to a specific stressful or traumatic event or experience [67].
Social Support (ESSI) The ENRICHD (Enhancing Recovery in Coronary Heart) Social Support Instrument (ESSI) is a seven-item scale com-
prised from the Medical Outcomes Survey (MOS). It assesses four components of social support including emo-
tional, instrumental, informational and appraisal [68, 69].
Self-esteem (SE) The Single-Item Self-Esteem Scale is a one-item scale developed as an alternative of the Rosenburg Self-Esteem
scale [70].
Resilience (RS-14) Resilience Scale (RS-14) is a 14-item questionnaire that assesses individual resilience in a general population [71].
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Table 3 Socio-demographic, clinical, psychosocial and lifestyle
characteristics of study population, (n = 1022)
Variable n(%)
Socio-demographic factors
Age, mean (SD) 58.9 ± 10.1
Gender
Female 272 (26.6)
Male 750 (73.4)
Marital status
Married 926 (90.6)
Not married 96 (9.4)
Residence
City 474 (46.4)
Village 473 (46.3)
Camp 75 (7.3)
Education degree
No HS diploma 600 (58.7)
HS diploma 167 (16.3)
College degree 255 (25.0)
Occupation
Professional 209 (20.5)
Non-professional 307 (30.0)
Unemployed 378 (37.0)
Retired 81 (7.9)
House wife 47 (4.6)
Clinical factors
Cardiac diagnosis
CAD 334 (32.7)
MI 406 (39.7)
Angina 162 (15.9)
Other 120 (11.7)
Previous cardiac diagnosis
Yes 690 (67.5)
No 332 (32.5)
Years with cardiac disease
≤ 1 year 628 (61.5)
2–9 years 255 (24.9)
≥ 10 years 139 (13.6)
Cardiac treatment (at admission)
CATH/stent 534 (52.2)
CATH/CABG 240 (23.5)
CATH/other & unknown 248 (24.3)
Co-morbidities
None 299 (29.3)
One 303 (29.6)
Two or more 420 (41.1)
Table 3 Socio-demographic, clinical, psychosocial and lifestyle
characteristics of study population, (n = 1022) (Continued)
Variable n(%)
Medications
None 132 (12.9)
1–2 152 (14.9)
3–4 738 (72.2)
Somatic symptoms (PHQ-15)
Minimal 91 (8.9)
Low 241 (23.6)
Medium 314 (30.7)
High 376 (36.8)
Family history
Yes 614 (60.1)
No 408 (39.9)
QoL, (SF-12-PCS score),
mean (SD)
37.6 ± 12.4
Psychosocial factors
PTSD (PTSD-PCL-S)
Minimal 611 (59.7)
Some 95 (9.3)
Moderate 253 (24.8)
High 63 (6.2)
Social support (ESSI)
Low 364 (35.6)
High 658 (64.4)
Resilience (RS)
Very low 92 (9.0)
Low 103 (10.1)
Low-end 204 (20.0)
Moderate 257 (25.1)
Moderately-high 274 (26.8)
High 92 (9.0)
Self-esteem (SE) score,
mean (SD)
5.8 ± 1.4
QoL,(SF-12-MCS score),
mean (SD)
39.7 ± 13.2
Lifestyle factors
Smoking status
Never 364 (35.6)
Former 170 (16.6)
Current 488 (47.8)
Currently on diet
Yes 170 (16.6)
No 852 (83.4)
Fat consumption
Low 480 (47.0)
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while 33.9% reported mild-to-moderate anxiety and
19.2% reported severe-to-very severe anxiety symptoms.
According to the stress scale, 62.6% reported having no
stress, 30% reported having mild-moderate stress symp-
toms and 7.4% severe-very severe stress symptoms.
Patients that had mild-moderate and severe-very severe
symptoms of depression or anxiety according to the
DASS-42 were more likely to have severe depressive
symptoms on the CDS. Nevertheless, 8 (4.0%) and 9
(4.6%) patients without any signs of depressive symp-
toms on the CDS, showed symptoms of depression and
anxiety, respectively, on the DASS-42.
Unadjusted correlations between continuous scores of
the scales used in study
Spearman correlation coefficients were calculated be-
tween the CDS and other instruments used in the study
(see Fig. 1). The correlation of the CDS with the DASS-
depression was =0.57 (p = < 0.001), with DASS-stress
=0.51 (p < 0.001), and with DASS-anxiety =0.50 (p <
0.001). The correlations between the DASS subscales
were as follows: DASS-depression and DASS-anxiety
(0.65, p < 0.001); DASS-depression and DASS-stress
(0.63, p < 0.001); DASS-anxiety and DASS-stress (0.61, p
< 0.001). CDS was positively correlated with the PHQ-15
(0.44, p < .001) and the PTSD-PCL-S (0.37, p < .001)and
the DASS-depression was also positively correlated with
the PTSD-PCL-S (0.57, p < .001).
The above cluster of positively associated factors were
weakly correlated to the physical and mental QoL com-
ponents of the SF-12, social support, resilience, and
self-esteem, which were strongly correlated among each
other. Specifically, weak correlations were observed be-
tween CDS and the SF-12-MCS (− 0.39, p < 0.001),
SF-12-PCS (− 0.29, p < 0.001), ESSI (− 0.12 p < 0.001),
RS-14 (− 0.24, p < 0.001) and with the self-esteem scale
(− 0.23, p < 0.001).
Table 3 Socio-demographic, clinical, psychosocial and lifestyle
characteristics of study population, (n = 1022) (Continued)
Variable n(%)
Medium 323 (31.6)
High 219 (21.4)
Vegetable & fruit
consumption
Low 102 (10.0)
Medium 353 (34.5)
High 567 (55.5)
Alcohol use, (n = 1019)
Yes 49 (4.8)
No 973 (95.2)
Physical activity
None 337 (33.0)
Not daily 189 (18.5)
Daily 496 (48.5)
Note. HS High school, MI Myocardial infarction, CAD Coronary artery disease,
CATH Catheterization, CABG Coronary artery bypass graft, CVD Cardiovascular
disease, PHQ-15 Patient health questionnaire-15, PCS Physical component
summary, QoL Quality of life, SD Standard deviation, PTSD Post-traumatic
stress disorder, PTSD-PCL-S Post-traumatic stress disorder checklist, ESSI
ENRICHD social support instrument, RS-14 Resilience scale-14, MCS Mental
component summary, BMI Body mass index
Table 4 Proportion of patients with CDS-depression, DASS-depression, DASS-anxiety, DASS-stress at different severity levels (n =
1022)
Depression, anxiety, stress according to CDS levels
Normal
n (%)
Mild- Moderate
n (%)
Severe-very severe
n (%)
Percentage above
normal level
CDS CDS < 90
218 (21.3)
CDS 90–100
257 (25.2)
CDS > 100
547 (53.5)
78.7
DASS-depression (D≥ 10) 481 (47.1) 341 (33.4) 200 (19.5) 52.9
Normal (0–9) 166 (34.5) 164 (35.1) 151 (31.4)
Mild/moderate (10–20) 44 (12.9) 82 (24.1) 215 (63.1)
Severe/very severe (21–42) 8 (4.0) 11 (5.5) 181 (90.5)
DASS-anxiety, (A ≥ 7) 479 (46.9) 347 (33.9) 196 (19.2) 53.1
Normal (0–6) 152 (31.7) 164 (34.2) 163 (34.0)
Mild/moderate (7–14) 57 (16.4) 77 (22.2) 213 (61.4)
Severe/very severe (15–42) 9 (4.6) 16 (8.2) 171 (87.2)
DASS-stress, (S≥ 15) 640 (62.6) 307 (30.0) 75 (7.4) 37.4
Normal (0–14) 178 (27.8) 206 (32.2) 256 (40.0)
Mild/moderate (15–25) 36 (11.7) 44 (14.3) 227 (73.9)
Severe/very severe (26–42) 4 (5.3) 7 (9.3) 64 (85.3)
Note. CDS Cardiac depression scale, DASS Depression, anxiety, stress scale
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Association between socio-demographic, clinical,
psychosocial, lifestyle factors and depressive and anxiety
symptoms
The bivariate distribution of socio-demographic, clinical,
psychological, and lifestyle characteristics according to
the presence or absence of depression symptoms (CDS),
anxiety symptoms (DASS-anxiety) and stress symptoms
(DASS-stress) is presented in Additional file 3: Table S1
(depression (CDS) and anxiety) and Additional file 2:
Table S2 (stress). Briefly, with regard to socio-demographic
factors, bivariate analysis revealed depressive and anxiety
symptoms were more frequent among females than males
(depression: 84.9% vs. 76.4%, p = 0.003; anxiety: 72.4% vs.
55.6%, p = < 0.001) and among those with lower educa-
tional level (depression: 81.0% [no high school diploma]
vs. 78.0% [high school diploma] and 71.1% [college
degree], p = 0.02; anxiety: 63.2% [no high school diploma]
vs. 59.8% (high school diploma) and 52.8% (college de-
gree), p < 0.05). Both, depressive and anxiety symptoms
were most prevalent among those unemployed and house-
wives (depression: p < 0.001; anxiety: p < 0.001).
Multivariable ordered logistic regression was performed
to determine the independent association of factors in the
four predictor blocks with a) depressive symptoms, cate-
gorized as no depressive symptoms, moderate depressive
symptoms, and severe depressive symptoms according to
the CDS and b) anxiety symptoms, categorized as minimal
anxiety symptoms, mild-moderate anxiety symptoms, and
severe-severe anxiety symptoms according to the
DASS-anxiety subscale. The results for the four blocks of
variables are presented in Table 5.
Overall, most of the psychosocial factors were consist-
ently associated with both, depression and anxiety. Partici-
pants with depression or anxiety were more likely to
exhibit at least some symptoms of PTSD. Odds ratios
tended to be higher for anxiety than for depression (mod-
erate symptoms vs. minimal symptoms: ORdepresssion 1.87
(95% CI 1.29–2.71) vs. ORanxiety 3.01 (95% CI 2.12–4.27).
Patients with depression or anxiety had a lower score for
the mental component of QoL (SF-12-MCS) [ORdepression
0.96 (95% CI 0.95–0.97); ORanxiety 0.98 (95% CI 0.97–
0.99)]. High resilience and high social support were in-
versely associated with depression and anxiety [high vs.
low social support: ORdepression 0.71 (95% CI 0.52–0.97);
ORanxiety 0.74 (95% CI 0.54–1.00)]. The inverse association
with resilience tended to be stronger in the presence of
anxiety [high vs. very low resilience: ORdepression 0.42 (95%
CI 0.18–0.94); ORanxiety 0.22 (95% CI 0.11–0.48)].
In addition to psychosocial factors, the physical com-
ponent of QoL (SF-12-PCS) and somatic symptoms
Fig. 1 Spearmen correlations between CDS, DASS-depression, DASS-anxiety, DASS-stress and other instruments used in the study. Note. CDS =
Cardiac Depression Scale; PHQ = Patient Health Questionnaire-15; PTSD = Post-Traumatic Stress Disorder; MCS =Mental Component Summary;
PCS = Physical Component Summary; RS = Resilience Scale-14; SE = Self-esteem; ESSI = ENRICHD Social Support Instrument. Blue colors represent
positive correlations and red colors represent negative correlations. Correlations measured are expressed as rho spearman.
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Table 5 Factors associated with DEPRESSION and ANXIETY in multivariate ordered logistic regression
Variable Depression (CDS) Anxiety (DASS-anxiety)
OR 95% CI P value OR 95% CI P value
Socio-demographic factors
Age, mean (SD) 0.99 (0.98–1.00) 0.393 0.96 (0.95–0.99) < 0.001
Gender
Female (reference) (reference)
Male 0.83 (0.51–1.36) 0.469 0.68 (0.43–1.10) 0.117
Marital status
Married (reference) (reference)
Not married 0.38 (0.22–0.65) 0.001 1.28 (0.76–2.13) 0.350
Residence
City (reference) (reference)
Village 1.22 (0.91–1.64) 0.191 0.74 (0.54–1.00) 0.054
Camp 1.35 (0.76–2.40) 0.308 0.56 (0.31–1.01) 0.054
Education degree
No HS diploma (reference) (reference)
HS diploma 1.15 (0.82–1.62) 0.421 0.93 (0.65–1.31) 0.666
College degree 1.19 (0.76–1.87) 0.449 1.09 (0.68–1.76) 0.715
Occupation
Professional (reference) (reference)
Non-professional 0.85 (0.55–1.31) 0.472 1.15 (0.73–1.81) 0.544
Unemployed 1.12 (0.67–1.88) 0.662 0.89 (0.54–1.48) 0.660
Retired 0.71 (0.38–1.33) 0.289 1.44 (0.75–2.73) 0.269
House wife 0.33 (0.14–0.80) 0.014 0.65 (0.27–1.56) 0.335
Clinical Factors
Cardiac diagnosis
CAD 0.89 (0.63–1.25) 0.508 0.75 (0.53–1.07) 0.111
MI (reference) (reference)
Angina 1.26 (0.83–1.92) 0.271 0.54 (0.35–0.86) 0.009
Other 0.82 (0.49–1.37) 0.440 1.23 (0.76–1.99) 0.407
Previous cardiac diagnosis
Yes 0.67 (0.47–0.96) 0.028 1.52 (1.05–2.21) 0.026
No (reference) (reference)
Years with cardiac disease
≤ 1 year (reference) (reference)
2–9 years 1.46 (1.00–2.13) 0.048 1.10 (0.76–1.59) 0.663
≥ 10 years 1.71 (1.06–2.75) 0.028 0.95 (0.60–1.50) 0.832
Cardiac treatment (at admission)
CATH/stent (reference) (reference)
CATH/CABG 1.42 (0.98–2.04) 0.065 0.89 (0.62–1.29) 0.558
CATH/other & unknown 1.34 (0.95–1.89) 0.097 1.44 (1.02–2.04) 0.036
Co-morbidities
None (reference) (reference)
1 0.93 (0.64–1.34) 0.695 0.96 (0.65–1.43) 0.860
2+ 1.39 (0.94–2.04) 0.096 1.36 (0.92–2.01) 0.127
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Table 5 Factors associated with DEPRESSION and ANXIETY in multivariate ordered logistic regression (Continued)
Variable Depression (CDS) Anxiety (DASS-anxiety)
OR 95% CI P value OR 95% CI P value
Medications
None (reference) (reference)
1–2 1.33 (0.78–2.29) 0.293 1.20 (0.68–2.10) 0.521
3–4 1.19 (0.74–1.92) 0.470 1.31 (0.79–2.18) 0.299
Somatic symptoms (PHQ-15)
Minimal (reference) (reference)
Low 1.18 (0.72–1.94) 0.506 1.41 (0.74–2.72) 0.296
Medium 1.86 (1.12–3.08) 0.015 3.35 (1.76–6.35) < 0.001
High 3.00 (1.73–5.18) < 0.001 7.64 (3.96–14.78) < 0.001
Family history
Yes 1.03 (0.77–1.38) 0.824 0.76 (0.57–1.03) 0.075
No (reference) (reference)
QoL, (SF-12-PCS score) 0.98 (0.97–1.00) 0.015 0.97 (0.96–0.99) < 0.001
Psychosocial factors
PTSD (PTSD-PCL-S)
Minimal (reference) (reference)
Some 1.32 (0.83–2.10) 0.247 2.34 (1.47–3.71) < 0.001
Moderate 1.87 (1.29–2.71) 0.001 3.01 (2.12–4.27) < 0.001
High 1.28 (0.00) 0.974 7.37 (3.89–14.0) < 0.001
Social support (ESSI)
Low (reference) (reference)
High 0.71 (0.52–0.97) 0.032 0.74 (0.54–1.00) 0.049
Resilience (RS-14)
Very low (reference) (reference)
Low 1.05 (0.49–2.25) 0.896 0.76 (0.41–1.41) 0.381
Low-end 0.78 (0.39–1.56) 0.479 0.43 (0.25–0.77) 0.004
Moderate 0.60 (0.30–1.21) 0.154 0.37 (0.20–0.66) 0.001
Moderately-high 0.48 (0.23–0.98) 0.044 0.19 (0.10–0.36) < 0.001
High 0.42 (0.18–0.94) 0.035 0.22 (0.11–0.48) < 0.001
Self-esteem (SE) score 0.97 (0.85–1.10) 0.640 0.85 (0.76–0.96) 0.007
QoL,(SF-12-MCS score) 0.96 (0.95–0.97) < 0.001 0.98 (0.97–0.99) < 0.001
Lifestyle factors
Smoking status
Never (reference) (reference)
Former 1.87 (1.17–2.97) 0.008 0.71 (0.44–1.14) 0.154
Current 1.61 (1.11–2.33) 0.013 1.37 (0.93–2.02) 0.106
Currently on diet
Yes 0.59 (0.40–0.86) 0.007 1.45 (0.98–2.13) 0.060
No (reference) (reference)
Fat consumption
Low (reference) (reference)
Medium 0.73 (0.53–1.00) 0.054 1.09 (0.79–1.51) 0.583
High 0.79 (0.55–1.14) 0.206 1.28 (0.88–1.86) 0.187
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(PHQ-15) also showed consistent associations with both
depression and anxiety [high vs. minimal somatic symp-
toms: ORdepression 3.00 (95% CI 1.73–5.18); ORanxiety 7.64
(95% CI 3.96–14.78)]; [SF-12-PCS: ORdepression 0.98 (95%
CI 0.97–1.00); ORanxiety 0.97 (95% CI 0.96–0.99)].
Current smoking was associated with depression with
the strongest odds ratio observed for depression and
former smoking: OR 1.87 (95% CI 1.17–2.97). Finally,
patients with depression and anxiety were more likely to
be physically inactive compared to patients without the re-
spective psychological problems.
A few factors exhibited associations with only one of
the two mental health outcomes. For example, patients
residing in villages or camps were less likely to show
symptoms of anxiety compared to patients living in the
city [(ORvillage 0.74 (0.54–1.00); ORcamp 0.56 (0.31–
1.01)]. Unemployment was positively associated with
depression, but not anxiety. The presence of previous
cardiac diagnoses was positively associated with anxiety,
but inversely associated with depression [(ORdepression
0.67 (95% 0.47–0.96); ORanxiety 1.52 (95% 1.05–2.21)].
Symptoms of depression were more frequent among
patients with a cardiac diagnosis for more than 10 years
compared to patients with a diagnosis for a year or less
[years since first diagnosis ≥10 vs. ≤ 1 year OR 1.71 (95%
1.06–2.75)]. Patients who were diagnosed with angina
were more likely to have anxiety symptoms than those
diagnosed with an MI. Underweight and obese partici-
pants were more likely to exhibit symptoms of anxiety
than those of normal weight and overweight.
Reliability assessment (Cronbach’s alpha) of the study
instruments
Cronbach α for the primary outcome variable, CDS was
0.86 and 0.92 (DASS-depression), 0.82 (DASS-anxiety),
and 0.89 (DASS-stress) for the DASS subscales, respect-
ively, indicating high consistency for the relevant psycho-
metric scales. This indicates all scales exhibit acceptable
internal consistency with little likelihood of item redun-
dancy. Inter-item correlations between the 26 items of the
CDS and the total CDS scores ranged from 0.08 to 0.58,
and all correlations were statistically significant at the 0.01
level. Cronbach α for the other scales used in the study
was: 0.78 for PHQ-15, 0.86 for PTSD-PCL-S, 0.82 for ESSI
and 0.88 for RS-14.
Discussion
In the present study, the observed rates of depressive and
anxiety symptoms were high. Only 21% (CDS) and 46%
(DASS-anxiety) of patients did not exhibit any symptoms
of depression and anxiety, respectively. Our findings point
to the need for integrating mental health care into cardiac
Table 5 Factors associated with DEPRESSION and ANXIETY in multivariate ordered logistic regression (Continued)
Variable Depression (CDS) Anxiety (DASS-anxiety)
OR 95% CI P value OR 95% CI P value
Vegetable & fruit consumption
Low (reference) (reference)
Medium 0.83 (0.50–1.37) 0.466 0.52 (0.31–0.86) 0.011
High 0.73 (0.45–1.19) 0.207 0.80 (0.49–1.30) 0.375
Alcohol use
Yes 1.31 (0.66–2.61) 0.439 1.19 (0.63–2.24) 0.591
No (reference) (reference)
Physical activity
None (reference) (reference)
Not daily 0.64 (0.42–0.98) 0.040 0.57 (0.37–0.87) 0.009
Daily 0.43 (0.30–0.60) < 0.001 0.98 (0.70–1.38) 0.908
BMI
Underweight 0.63 (0.05–7.7) 0.720 2.09 (0.22–19.9) 0.522
Normal weight (reference) (reference)
Overweight 0.81 (0.55–1.18) 0.272 0.61 (0.42–0.89) 0.010
Obese 0.95 (0.63–1.43) 0.824 0.87 (0.59–1.29) 0.495
Note. Multivariate ordered logistic regression reported for socio-demographic, clinical, psychosocial and lifestyle factors associated with depression, CDS (not
depressed; mild-moderate depression; severely-very severe depression) and DASS-anxiety (no anxiety, mild-moderate anxiety; severe-very severe anxiety). Analyses
were performed in two separate models for depression and anxiety, mutually adjusting for all factors in the four predictor blocks in both models. Analyses are
also adjusted for the hospital to which patients were admitted. OR Odds ratio, CI Confidence Interval, SD Standard deviation, HS High school, MI Myocardial
infarction, CAD Coronary artery disease, CATH Catheterization, CABG Coronary artery bypass graft, PHQ-15 Patient health questionnaire-15, PCS Physical component
summary, PTSD Post-traumatic stress disorder, PTSD-PCL-S Post-traumatic stress disorder checklist, ESSI ENRICHD social support instrument, RS-14 Resilience scale-
14, MCS Mental component summary, BMI Body mass index; P values in bold are significant at p < 0.05
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treatment. It is noteworthy that several factors found to
be associated with depression and anxiety may serve as
screening and possibly as intervention targets.
Rates of mental health problems reported in earlier
studies for patients with different cardiac diagnoses and
in different cultural and health system settings ranged
from 14 to 73% [33–38] for depressive symptoms and 15
to 48% [33–37] for anxiety symptoms. These varying
rates are explained in part by differences in sample sizes,
the instruments and cutoffs used for classifying depres-
sion and anxiety and the type of cardiac disease targeted
in studies.
Lower rates of depression than in the current study
were observed in other settings including Norway (14%)
[33], USA (15%) [39], Brazil (26.4%) [34] and Pakistan
(14%) [36]. Similar among these studies, was the common
psychiatric instruments used to assess for depression, all
of which were not specific for cardiac populations. In con-
trast, a different study assessing depression using the CDS
found a rate of 73.2% of severe depression in Iranian
patients with acute coronary syndrome (ACS), a rate even
higher than in this study [38].
Similar anxiety rates to the current study were observed
in Iran (28.5%) [37] and Pakistan (18%) [36]. Interestingly,
in another study conducted in Brazil, Meneghetti et al.
found a very high prevalence of 48.4% for anxiety symp-
toms among ACS patients using the Hospital Anxiety and
Depression Scale (HADS) [34]. A study in the USA also
reported, 37% of patients with MI due to spontaneous cor-
onary artery dissection screened for anxiety using the
Generalized Anxiety Disorder 7-Item Scale (GAD-7) [35].
Mental health problems are generally high in the Pal-
estinian population [31]. In the absence of a healthy con-
trol group the results of this study do not allow to
conclude that depression and anxiety are more common
in cardiac patients. However, cardiac patients are in par-
ticular need of treatment for depression and anxiety
given that existing evidence points to their adverse effect
on the course of heart disease. Furthermore, cardiac
rehabilitation may be an efficient starting point to ad-
dress mental health issues beyond the patient and to the
extended family and social network. Given the shortage
of mental health services available and the local eco-
nomic instability in Palestine, the provision of additional
services needs to be implemented in a cost-effective way.
The identification of subgroups of cardiac patients at
higher risk of depression and anxiety can guide screen-
ing and interventions.
In perspective of mental health screening among car-
diac patients, focus should be given to females and less
educated patients. The higher rates of depression and
anxiety seen in these sub-groups were previously de-
scribed in literature [34, 37, 40, 41]. Women seem to be
more vulnerable to the trauma caused by cardiac events,
which leads to a deterioration in depression and anxiety
symptoms [37]. As observed in some [34, 42, 43], but
not all studies [37, 38, 44], the association between gen-
der and social status may not be direct as suggested by
the disappearance of gender and social status differences
in the fully adjusted models [34, 37, 38, 42].
The presence of the following additional characteristics
in cardiac patients should be a red flag for cardiologists to
consider mental health care in cardiac practice: symptoms
of PTSD, low levels of self-esteem, somatic symptoms, low
QoL components, active smoking, physical inactivity, and
longer disease duration. In contrast, a high level of resili-
ence seems to reduce symptoms of psychological prob-
lems, as previously observed in patients with heart failure
[45, 46]. Unlike findings reported previously, comorbidi-
ties were not consistently more common in the presence
of mental health disorders [47]. Little is known about the
association of PSTD symptoms with depression and anx-
iety in cardiac patients. A study conducted on 813 patients
who received angiograms at a large U.S. Veterans Admin-
istration Medical Center found depression to be positively
associated with PTSD, smoking and alcohol consumption
[48]. Low MCS and PCS scores on the SF-12, smoking,
and chest pain were recently identified as the strongest
predictors of longitudinally sustained high levels of de-
pression and anxiety in CHD patients [24].
Factors serving as targets for intervention include
smoking, physical activity and social support. Smoking
cessation interventions are crucial for cardiac rehabilita-
tion, however in the presence of depression, results are
less successful and interventions may need to be adapted
[49]. Sedentary behavior, a risk factor for depression in
the general population [50], was previously associated
with depression according to the Beck Depression In-
ventory-II in patients hospitalized for ACS [51]. In a
small non-randomized intervention study with heart fail-
ure patients, aerobic interval training decreased symp-
toms of depression over a period of 12-weeks [52]. In
studies on breast cancer [53], promotion of physical ac-
tivity may have the additional benefit of improving self-
esteem, a factor associated with depression and anxiety
in this study and a predictor of mortality in the general
population [54]. In addition, according to previous stud-
ies [43, 55–58], the inverse association between high
social support and low levels of anxiety and depression
points to another important target for prevention as it is
supported by firm evidence from previous studies. Poor
social support among patients with ACS was observed
in secondary analyses of a randomized trial to reduce
the effectiveness of treatment with antidepressants [59].
The quality of social support plays an important role, as
overprotective behaviors of partners can have an adverse
effect [58]. Interestingly, in the current study marital sta-
tus and social support were associated with presence of
Allabadi et al. BMC Public Health          (2019) 19:232 Page 11 of 14
depressive symptoms independently and in opposite
directions.
The current study has several strengths. First, it uti-
lized a broad set of validated instruments to identify
depression and anxiety symptoms as well as associated
factors. The overall validity of the CDS in this study was
almost similar to levels originally reported by Hare and
Davis [60]. The validity of the DASS-42 was satisfactory,
in line with other findings of other studies, including
those originally reported by Lovibond and Lovibond
[61]. Furthermore, the CDS is the only psychometric
scale suitable for the comparative depression assessment
in heart disease patients, subjected to different interven-
tions [60, 62] . This is evident in the present study, as
depression rates were lower when assessed by the
DASS-42. The CDS, also has excellent properties for the
diagnosis of MDD, a score of ≥95 having a 97% sensitiv-
ity at 85% specificity (AUC 0.96) [62]. Second, the large
sample size provided sufficient statistical power for test-
ing independent associations. Third, the study subjects
are well characterized, which allowed for addressing
confounding. Fourth, the high participation rate de-
creased the likelihood of selection and participation bias.
Finally, the findings of the study despite being hospital-
based are likely generalizable to the entire cardiac pa-
tient population in the city of Nablus and surrounding
cities of Palestine, considering the study sites provide
cardiac care to a large percentage of cardiac patients in
the area.
Nonetheless, the cross-sectional nature of the study
does not enable us to make causal inferences. A long-term
follow-up is foreseen to investigate the predictive effect of
the study characteristics and predictors with regard to the
course of depression, anxiety and heart disease. While the
reliability of the previously validated instruments was con-
firmed in our study, the instruments have not been vali-
dated specifically for the context of cardiac patients in
Palestine. Furthermore, some of the risk factors could only
be captured broadly to avoid lengthy interviews. This
likely caused some misclassification, as in the case of
physical activity. Recall bias may have added to the mis-
classification of risks, given the retrospective nature of the
interview. Also, the study was not sufficiently powered to
investigate differences in the frequency of depression and
anxiety as well as associated factors between relevant sub-
groups of clinical diagnoses, for example MI and HF.
Finally, some patients were recruited at the time of admis-
sion and for the most part before receiving their interven-
tion or diagnosis, and thus were under much pressure and
stress. The level of depression and anxiety could have
been overestimated and may decrease in part over the
course of disease. The most appropriate time point to as-
sess depression and anxiety from a prognostic perspective
is unknown.
Conclusions
The alarmingly high rate of depression and anxiety
symptoms observed in cardiac patients in Palestine
points to the need for integrating mental health care into
cardiac rehabilitation. The prognostic value of depres-
sion and anxiety with regard to the course of heart
disease, adherence to treatment and quality of life needs
to be investigated. Treatment of psychological problems
from the disease onset and onwards is crucial consider-
ing longer disease duration puts individuals at higher
risk of being depressed. The expertise of social scientists
and medical anthropologists is needed for identifying
efficient means to overcome barriers related to the
stigmatization of psychological disorders.
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